12-111792717-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000261733.7(ALDH2):c.1018G>A(p.Val340Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000441 in 1,586,802 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000046 ( 0 hom. )
Consequence
ALDH2
ENST00000261733.7 missense
ENST00000261733.7 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 4.63
Genes affected
ALDH2 (HGNC:404): (aldehyde dehydrogenase 2 family member) This protein belongs to the aldehyde dehydrogenase family of proteins. Aldehyde dehydrogenase is the second enzyme of the major oxidative pathway of alcohol metabolism. Two major liver isoforms of aldehyde dehydrogenase, cytosolic and mitochondrial, can be distinguished by their electrophoretic mobilities, kinetic properties, and subcellular localizations. Most Caucasians have two major isozymes, while approximately 50% of East Asians have the cytosolic isozyme but not the mitochondrial isozyme. A remarkably higher frequency of acute alcohol intoxication among East Asians than among Caucasians could be related to the absence of a catalytically active form of the mitochondrial isozyme. The increased exposure to acetaldehyde in individuals with the catalytically inactive form may also confer greater susceptibility to many types of cancer. This gene encodes a mitochondrial isoform, which has a low Km for acetaldehydes, and is localized in mitochondrial matrix. Alternative splicing results in multiple transcript variants encoding distinct isoforms.[provided by RefSeq, Nov 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.17337942).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALDH2 | NM_000690.4 | c.1018G>A | p.Val340Ile | missense_variant | 9/13 | ENST00000261733.7 | NP_000681.2 | |
ALDH2 | NM_001204889.2 | c.877G>A | p.Val293Ile | missense_variant | 8/12 | NP_001191818.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALDH2 | ENST00000261733.7 | c.1018G>A | p.Val340Ile | missense_variant | 9/13 | 1 | NM_000690.4 | ENSP00000261733 | P1 | |
ALDH2 | ENST00000416293.7 | c.877G>A | p.Val293Ile | missense_variant | 8/12 | 2 | ENSP00000403349 | |||
ALDH2 | ENST00000549106.1 | c.109G>A | p.Val37Ile | missense_variant, NMD_transcript_variant | 1/4 | 3 | ENSP00000474669 | |||
ALDH2 | ENST00000548536.1 | c.*894G>A | 3_prime_UTR_variant, NMD_transcript_variant | 10/14 | 3 | ENSP00000448179 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151754Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
151754
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000501 AC: 10AN: 199536Hom.: 0 AF XY: 0.0000651 AC XY: 7AN XY: 107480
GnomAD3 exomes
AF:
AC:
10
AN:
199536
Hom.:
AF XY:
AC XY:
7
AN XY:
107480
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000460 AC: 66AN: 1434930Hom.: 0 Cov.: 31 AF XY: 0.0000478 AC XY: 34AN XY: 711652
GnomAD4 exome
AF:
AC:
66
AN:
1434930
Hom.:
Cov.:
31
AF XY:
AC XY:
34
AN XY:
711652
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151872Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74214
GnomAD4 genome
AF:
AC:
4
AN:
151872
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74214
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
7
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 28, 2021 | The c.1018G>A (p.V340I) alteration is located in exon 9 (coding exon 9) of the ALDH2 gene. This alteration results from a G to A substitution at nucleotide position 1018, causing the valine (V) at amino acid position 340 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L
MutationTaster
Benign
D;D;D;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
0.0080
.;B
Vest4
MutPred
0.59
.;Loss of methylation at R342 (P = 0.1028);
MVP
MPC
0.26
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at